Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 85.24

+0.5%

Feb 4 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Jibacoa	7/17/2015 12:43:30 PM
	Read Replies (1) of 3722

OPHT has been on a steady gain since it started trading back in 2013.<g> Actually, the stock has made new highs every Quarter, except for the 3rdQ last year and the 2ndQ this year.<g> On the 2ndQ this year, the insiders reportedly sold around 12% of their holdings, while exercising options at lower prices.<g> The institutions bought, although not enough to counterbalance the selling by the insiders.<g> However, the institutions were right, since OPHT resumed its up-trend and continued to make new Hs this quarter.<g> Disclosure: I am long OPHT and think both of their drugs, ZOVISTA and ZIMURA have a good potential. <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next